These findings suggested our prepared thiolated nano‐vaccine could effectively prevent H22 tumor growth and prolong the survival time of inoculated mice through effective effector cell infiltration and activation of the CD8+T dependent immune responses. This evidence concerns the gene CD8A and neoplasm.